Anika Therapeutics, Inc. - Common Stock, par value $0.01 per share (ANIK)

CUSIP: 035255108

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
14,423,417
Total 13F shares
12,224,634
Share change
+24,701
Total reported value
$117,473,974
Price per share
$9.61
Number of holders
125
Value change
+$236,847
Number of buys
72
Number of sells
42

Quarterly Holders Quick Answers

What is CUSIP 035255108?
CUSIP 035255108 identifies ANIK - Anika Therapeutics, Inc. - Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Anika Therapeutics, Inc. - Common Stock, par value $0.01 per share (ANIK) as of Q4 2025

As of 31 Dec 2025, Anika Therapeutics, Inc. - Common Stock, par value $0.01 per share (ANIK) was held by 125 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,224,634 shares. The largest 10 holders included BlackRock, Inc., Caligan Partners LP, VANGUARD GROUP INC, MORGAN STANLEY, ACADIAN ASSET MANAGEMENT LLC, BOOTHBAY FUND MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, CAPITAL MANAGEMENT CORP /VA, DIMENSIONAL FUND ADVISORS LP, and STATE STREET CORP. This page lists 125 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.